EDGAR Filing Documents for 0001558370-23-005073

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-23-005073

Filing Date

2023-03-30

Accepted

2023-03-30 16:01:41

Documents

116

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	ymab-20221231x10k.htm iXBRL	10-K	2694606
2	EX-4.4	ymab-20221231xex4d4.htm	EX-4.4	37359
3	EX-10.41	ymab-20221231xex10d41.htm	EX-10.41	24169
4	EX-10.42	ymab-20221231xex10d42.htm	EX-10.42	332820
5	EX-21.1	ymab-20221231xex21d1.htm	EX-21.1	3072
6	EX-23	ymab-20221231xex23.htm	EX-23	2878
7	EX-31.1	ymab-20221231xex31d1.htm	EX-31.1	16173
8	EX-31.2	ymab-20221231xex31d2.htm	EX-31.2	16368
9	EX-32.1	ymab-20221231xex32d1.htm	EX-32.1	6900
10	EX-32.2	ymab-20221231xex32d2.htm	EX-32.2	6402
11	GRAPHIC	ymab-20221231x10k001.jpg	GRAPHIC	50143
12	GRAPHIC	ymab-20221231x10k002.jpg	GRAPHIC	49588
13	GRAPHIC	ymab-20221231x10k003.jpg	GRAPHIC	74205
14	GRAPHIC	ymab-20221231x10k005.jpg	GRAPHIC	14766
15	GRAPHIC	ymab-20221231x10k006.jpg	GRAPHIC	8612
16	GRAPHIC	ymab-20221231x10k007.jpg	GRAPHIC	27676
17	GRAPHIC	ymab-20221231x10k009.jpg	GRAPHIC	26727
18	GRAPHIC	ymab-20221231x10k010.jpg	GRAPHIC	17152
	Complete submission text file	0001558370-23-005073.txt		11412813

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	ymab-20221231.xsd	EX-101.SCH	84523
20	EX-101.CAL	ymab-20221231_cal.xml	EX-101.CAL	64830
21	EX-101.DEF	ymab-20221231_def.xml	EX-101.DEF	326617
22	EX-101.LAB	ymab-20221231_lab.xml	EX-101.LAB	645832
23	EX-101.PRE	ymab-20221231_pre.xml	EX-101.PRE	555544
110	EXTRACTED XBRL INSTANCE DOCUMENT	ymab-20221231x10k_htm.xml	XML	1523039

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169

Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841

Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)